The Cys-67 residue of HLA-B27 influences cell surface stability, peptide specificity, and T-cell antigen presentation

被引:38
作者
Alvarez, I
Martí, M
Vázquez, J
Camafeita, E
Ogueta, S
de Castro, JAL [1 ]
机构
[1] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Fac Ciencias, CSIC, E-28049 Madrid, Spain
[2] Ctr Nacl Biotecnol, Madrid 28049, Spain
关键词
D O I
10.1074/jbc.M108882200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cys-67 of HLA-B27 is located in the B pocket, which determines peptide-binding specificity. We analyzed effects of the Cys-67 --> Ser mutation on cell surface expression, peptide specificity, and T-cell recognition of HIA-B*2705. Surface expression was assessed with antibodies recognizing either native or unfolded HILA proteins. Whereas native B*2705 molecules predominated over unfolded ones, this ratio was reversed in the mutant, suggesting lower stability. Comparison of B*2705and Cys-67 --> Ser-bound peptides revealed that the mutant failed to bind similar to15% of the B*2705 ligands, while binding as many novel ones. Two peptides with Gln-2 found in both B*2705 and Cys-67 --> Ser are the first demonstration of natural 13*2705 ligands lacking Arg-2. Other effects of the mutation on peptide specificity were: 1) average molecular mass of natural ligands higher than for B*2705, 2) bias against small residues at peptide position (P) 1, and 3) increased P2 permissiveness. The results suggest that the Cys-67 --> Ser mutation weakens B pocket interactions, leading to decreased stability of the mutant-peptide complexes. This may be partially compensated by interactions involving bulky P1 residues. The effect of the mutation on allorecognition was consistent with that on peptide specificity. Our results may aid understanding of the pathogenetic role of HIA-B27 in spondyloarthropathy.
引用
收藏
页码:48740 / 48747
页数:8
相关论文
共 58 条
[1]   The role of HLA-B27 in spondyloarthritis [J].
Allen, RL ;
Bowness, P ;
McMichael, AJ .
IMMUNOGENETICS, 1999, 50 (3-4) :220-227
[2]  
Allen RL, 1999, J IMMUNOL, V162, P5045
[3]   Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20 S proteasome [J].
Alvarez, I ;
Sesma, L ;
Marcilla, M ;
Ramos, M ;
Martí, M ;
Camafeita, E ;
de Castro, JAL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (35) :32729-32737
[4]   ALLOREACTIVE CYTOLYTIC T-CELL CLONES WITH DUAL RECOGNITION OF HLA-B27 AND HLA-DR2 ANTIGENS - SELECTIVE INVOLVEMENT OF CD8 IN THEIR CLASS-I DIRECTED CYTOTOXICITY [J].
APARICIO, P ;
JARAQUEMADA, D ;
DECASTRO, JAL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) :428-443
[5]   PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS [J].
BARNSTABLE, CJ ;
BODMER, WF ;
BROWN, G ;
GALFRE, G ;
MILSTEIN, C ;
WILLIAMS, AF ;
ZIEGLER, A .
CELL, 1978, 14 (01) :9-20
[6]   GUILT BY ASSOCIATION - HLA-B27 AND ANKYLOSING-SPONDYLITIS [J].
BENJAMIN, R ;
PARHAM, P .
IMMUNOLOGY TODAY, 1990, 11 (04) :137-142
[7]   Differences in endogenous peptides presented by HLA-B*2705 and B*2703 allelic variants - Implications for susceptibility to spondylarthropathies [J].
Boisgerault, F ;
Tieng, V ;
Stolzenberg, MC ;
Dulphy, N ;
Khalil, I ;
Tamouza, R ;
Charron, D ;
Toubert, A .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2764-2770
[8]   REITERS DISEASE AND HL-A 27 [J].
BREWERTON, DA ;
NICHOLLS, A ;
OATES, JK ;
CAFFREY, M ;
WALTERS, D ;
JAMES, DCO .
LANCET, 1973, 2 (7836) :996-998
[9]  
BREWERTON DA, 1973, LANCET, V1, P904
[10]   CHARACTERIZATION OF A MONOCLONAL ANTI-BETA-2-MICROGLOBULIN ANTIBODY AND ITS USE IN THE GENETIC AND BIOCHEMICAL-ANALYSIS OF MAJOR HISTOCOMPATIBILITY ANTIGENS [J].
BRODSKY, FM ;
BODMER, WF ;
PARHAM, P .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1979, 9 (07) :536-545